Corvus Pharmaceuticals, Inc.
CRVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626971
No open-market purchases or sales by Corvus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 173 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Corvus Pharmaceuticals, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- −4 vs. Q3 2023
- Shares held
- 19.2M
- −2.90K (0.0%) vs. Q3 2023
- Total value
- $33.8M
- +$5.75M (+20.5%) vs. Q3 2023
- New holders
- 3
- 13 more added
- Sold out
- 7
- 11 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 173 | $1.06B |
| Q1 2026 | 164 | $1.02B |
| Q4 2025 | 124 | $359.4M |
| Q3 2025 | 103 | $312.7M |
| Q2 2025 | 92 | $167.1M |
| Q1 2025 | 88 | $115.4M |
| Q4 2024 | 86 | $202.0M |
| Q3 2024 | 62 | $158.5M |
| Q2 2024 | 47 | $50.2M |
| Q1 2024 | 47 | $31.9M |
| Q4 2023 | 48 | $33.8M |
| Q3 2023 | 52 | $28.0M |
| Q2 2023 | 52 | $44.6M |
| Q1 2023 | 37 | $18.9M |
| Q4 2022 | 42 | $18.2M |
| Q3 2022 | 48 | $18.1M |
| Q2 2022 | 47 | $25.4M |
| Q1 2022 | 57 | $44.9M |
| Q4 2021 | 62 | $66.7M |
| Q3 2021 | 61 | $136.4M |
| Q2 2021 | 50 | $63.2M |
| Q1 2021 | 49 | $62.8M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Corvus Pharmaceuticals, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 122 | $0 | 0.00% | +122 | New |
| Barclays PLC | 1 | $2 | 0.00% | −13,681−100.0% | Reduced |
| Parallel Advisors, LLC | 20 | $35 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 22 | $39 | 0.00% | −3,150−99.3% | Reduced |
| IFP Advisors, Inc | 24 | $42 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 260 | $458 | 0.00% | +13+5.3% | Added |
| JPMorgan Chase & Co | 679 | $1.20K | 0.00% | −69,228−99.0% | Reduced |
| Rhumbline Advisers | 791 | $1.39K | 0.00% | 00.0% | Unchanged |
| Natixis | 800 | $1.41K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,200 | $2.11K | 0.00% | −1,200−50.0% | Reduced |
| Northwest Capital Management Inc | 3,397 | $5.98K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 6,700 | $11.8K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 7,654 | $13.5K | 0.00% | +7,471+4,082.5% | Added |
| Tower Research Capital LLC (TRC) | 8,503 | $15.0K | 0.00% | −16,234−65.6% | Reduced |
| Masso Torrence Wealth Management Inc. | 10,000 | $17.6K | 0.01% | 00.0% | Unchanged |
| Whittier Trust Co of Nevada Inc | 11,200 | $19.6K | 0.00% | 00.0% | Unchanged |
| Gillespie Robinson & Grimm Inc | 11,480 | $20.2K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 11,924 | $21.0K | 0.00% | −2,966−19.9% | Reduced |
| Resources Investment Advisors, LLC. | 12,400 | $21.8K | 0.00% | +12,400 | New |
| Charles Schwab Investment Management Inc | 15,668 | $27.6K | 0.00% | 00.0% | Unchanged |
| American Century Companies Inc | 18,462 | $32.5K | 0.00% | −292−1.6% | Reduced |
| Commerce Bank | 20,000 | $35.2K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 21,219 | $37.3K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 23,095 | $40.6K | 0.00% | +23,095 | New |
| XTX Topco Ltd | 23,415 | $41.2K | 0.01% | +4,171+21.7% | Added |
| Group One Trading, L.P. | 36,664 | $64.5K | 0.00% | +9,565+35.3% | Added |
| Millennium Management LLC | 40,835 | $71.9K | 0.00% | −67,189−62.2% | Reduced |
| Simplex Trading, LLC | 49,631 | $87.0K | 0.00% | +10,138+25.7% | Added |
| Hikari Power Ltd | 49,959 | $88.0K | 0.01% | 00.0% | Unchanged |
| Jackson Square Capital, LLC | 63,773 | $112.2K | 0.04% | 00.0% | Unchanged |
| Northern Trust Corp | 65,017 | $114.4K | 0.00% | 00.0% | Unchanged |
| MYDA Advisors LLC | 71,011 | $125.0K | 0.06% | +2,197+3.2% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 71,208 | $125.3K | 0.00% | +325+0.5% | Added |
| State Street Corp | 138,403 | $243.6K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 149,300 | $262.8K | 0.01% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 180,704 | $318.0K | 0.00% | −92,303−33.8% | Reduced |
| Susquehanna International Group, LLP | 220,296 | $387.7K | 0.00% | +92,328+72.1% | Added |
| Two Sigma Advisers, LP | 235,600 | $414.7K | 0.00% | −13,300−5.3% | Reduced |
| Morgan Stanley | 259,655 | $457.0K | 0.00% | +67,149+34.9% | Added |
| Geode Capital Management, LLC | 360,380 | $634.4K | 0.00% | 00.0% | Unchanged |
| Towerview LLC | 436,873 | $768.9K | 0.47% | +94,395+27.6% | Added |
| BlackRock Inc. | 520,551 | $916.2K | 0.00% | −700−0.1% | Reduced |
| Renaissance Technologies LLC | 587,432 | $1.03M | 0.00% | +165,689+39.3% | Added |
| Vanguard Group Inc | 1,350,633 | $2.38M | 0.00% | +3,701+0.3% | Added |
| BVF Inc | 1,370,947 | $2.41M | 0.06% | 00.0% | Unchanged |
| Samlyn Capital, LLC | 2,496,259 | $4.39M | 0.10% | +90,495+3.8% | Added |
| Adams Street Partners LLC | 3,275,616 | $5.77M | 1.78% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 6,943,654 | $12.2M | 0.24% | 00.0% | Unchanged |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −198,220−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −49,324−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −17,366−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −15,617−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −13,050−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,232−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1,101−100.0% | Sold out |